These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1164 related items for PubMed ID: 9113120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Andersson H, Hansen O, Sørensen BT, Räisänen I.
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [Abstract] [Full Text] [Related]

  • 6. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
    Otten J, Hachimi-Idrissi S, Balduck N, Maurus R.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
    [Abstract] [Full Text] [Related]

  • 7. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
    Chiersilpa A, Ngow J.
    J Med Assoc Thai; 1999 Sep; 82(9):915-21. PubMed ID: 10561949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ, Cocquyt VF, Bleiberg H, Canon JL, Buyse M, Hulstaert F, De Witte M, De Keyser P, Westelinck K.
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of tropisetron and dexamethasone in the prevention of cisplatin-induced emesis.
    Voravud N, Suwanrusmee H.
    J Med Assoc Thai; 2000 Jun; 83(6):668-75. PubMed ID: 10932495
    [Abstract] [Full Text] [Related]

  • 15. Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
    Campora E, Giudici S, Merlini L, Rubagotti A, Rosso R.
    Am J Clin Oncol; 1994 Dec; 17(6):522-6. PubMed ID: 7977174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen BT, Räisänen I, van Oosterom AT, de Bruijn KM.
    Cancer; 1994 Jan 15; 73(2):445-54. PubMed ID: 8293412
    [Abstract] [Full Text] [Related]

  • 18. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J, Trnený M, Procházka B, Klener P.
    Neoplasma; 2000 Jan 15; 47(5):319-22. PubMed ID: 11130251
    [Abstract] [Full Text] [Related]

  • 19. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S, Akman SA, Ozgenç F, Kansoy S.
    Pediatr Hematol Oncol; 2001 Sep 15; 18(6):397-406. PubMed ID: 11554235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.